⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 9, 2019Expert Review of Molecular DiagnosticsOpen Access

Should next-generation sequencing tests be performed on all cancer patients?

Andrew J. McKenzie Holli H. Dilks Suzanne F. Jones Howard A. Burris

View Full Paper

Ask AI

Bookmark

Share

Abstract

Oncologists require as much data as possible in order to develop and execute the optimal treatment plan for their patients. Next-Generation Sequencing (NGS) provides rich data informing possible ta...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McKenzie et al. (2019) studied this question.

synapsesocial.com/papers/6ab35e7c23dc4f8dac45c7d3 https://doi.org/10.1080/14737159.2019.1564043

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutationsOriginal Research · 2016 · 93 citations
2The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal CancerEarly-Phase Clinical Trial · 2016 · 68 citations
3Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> FusionCohort Study · 2018 · 445 citations
4Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in OncologyOriginal Research · 2016 · 170 citations
5A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeOriginal Research · 2016 · 70 citations

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency2015
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden2018
Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies2013
Emerging precision diagnostics in genitourinary cancersExpert Review of Molecular Diagnostics · 2026
MRSA nasal PCR as a prevalence-dependent stewardship tool in hospitalized children: a structured reviewExpert Review of Molecular Diagnostics · 2026

More from Expert Review of Molecular Diagnostics

More from Sarah Cannon